<DOC>
	<DOC>NCT01683513</DOC>
	<brief_summary>In this study the investigators compare the traditional way of triggering with a new way in patients with Poly Cystic Ovary Syndrome (PCOS). This to reduce the risque of Ovary Hyper Stimulation Syndrome (OHSS) in In Vitro Fertilization/ IntraCytoplastic Sperm Injection (IVF/ ICSI) treatment. The investigators also compare the number of mature oocytes, embryo's and pregnancy rate.</brief_summary>
	<brief_title>Trial Comparing hCG Triggering Versus GnRH Agonist Triggering in PCOS Patients</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Deslorelin</mesh_term>
	<mesh_term>Triptorelin Pamoate</mesh_term>
	<criteria>ICSI patients below 38 years 1, 2 and 3e IVF cycle Body Mass Index (BMI) less than 32 PCOS patients endocrinal diseases or problems</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>38 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>OHSS</keyword>
	<keyword>mataphase II oocytes (MII)</keyword>
	<keyword>good quality embryo's</keyword>
	<keyword>pregnancy</keyword>
</DOC>